Northern Sydney Local Health District - Kolling Institute

Site

Cancer Genetics Diagnostic Laboratory – Kolling Institute

Accreditation No.

19626

Site No.

22731

Date of Accreditation

09 Dec 2014

Address

Level 9, Kolling Institute, Royal North Shore Hospital
St Leonards, NSW 2065
Australia

Contact

Assoc Prof Rory Clifton-Bligh P: +61 (02) 94631411

Availability

Services available to external clients

Supervision

S (Specialised)

Scope of Accreditation

ISO 15189 (2012)

Human Pathology

Medicare expiry date

28 Feb 2024

Last Activity Date

19 Nov 2020

Service Product Determinant

Suspended

Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Targeted genes
Extracted DNA Hyperparathyroidism - Jaw tumour syndrome; Parathyroid hormone (PTH); Thyroid stimulating hormone receptor (TSHR); Vitamin D 24-hydroxylase

Suspended

Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Targeted panels for inherited (germline) DNA/RNA changes
Extracted DNA Hyperparathyroidism - Jaw tumour syndrome; Parathyroid hormone (PTH); Thyroid stimulating hormone receptor (TSHR); Vitamin D 24-hydroxylase

Suspended

Molecular genetics - Heterozygous loci determinations
Extracted DNA Hyperparathyroidism - Jaw tumour syndrome; Parathyroid hormone (PTH); Thyroid stimulating hormone receptor (TSHR); Vitamin D 24-hydroxylase

Suspended

Molecular genetics - Predictive genetic testing - Targeted genes
Extracted DNA Hyperparathyroidism - Jaw tumour syndrome; Thyroid stimulating hormone receptor (TSHR); Vitamin D 24-hydroxylase

Suspended

Molecular genetics - Predictive genetic testing - Targeted panels for inherited (germline) DNA/RNA changes
Extracted DNA Hyperparathyroidism - Jaw tumour syndrome; Parathyroid hormone (PTH); Thyroid stimulating hormone receptor (TSHR); Vitamin D 24-hydroxylase

Suspended

Molecular genetics - Screening for an unknown mutation - Targeted genes
Extracted DNA Hyperparathyroidism - Jaw tumour syndrome; Parathyroid hormone (PTH); Thyroid stimulating hormone receptor (TSHR); Vitamin D 24-hydroxylase

Suspended

Molecular genetics - Screening for an unknown mutation - Targeted panels for inherited (germline) DNA/RNA changes
Extracted DNA Hyperparathyroidism - Jaw tumour syndrome; Parathyroid hormone (PTH); Thyroid stimulating hormone receptor (TSHR); Vitamin D 24-hydroxylase
Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Targeted genes Extracted DNA Calcium sensing receptor (CaSR gene mutation); Medullary thyroid cancer (RET gene mutation); Multiple endocrine neoplasia type 2 (MEN2); Nucleic acid analysis for specific variants; Sporadic and inherited neuroendocrine syndromes - Phaeochromocytomas and paragangliomas - SDHD,B,C,A TMEM127, fumarate hydratase, MAX gene mutations; Thyroid hormone receptor (THRB gene mutation); Von Hippel Lindau disease
Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Targeted panels for inherited (germline) DNA/RNA changes Extracted DNA Calcium sensing receptor (CaSR gene mutation); Medullary thyroid cancer (RET gene mutation); Multiple endocrine neoplasia type 2 (MEN2); Nucleic acid analysis for known variants; Sporadic and inherited neuroendocrine syndromes - Phaeochromocytomas and paragangliomas - SDHD,B,C,A TMEM127, fumarate hydratase, MAX gene mutations; Thyroid hormone receptor (THRB gene mutation); Von Hippel Lindau disease
Molecular genetics - Heterozygous loci determinations Extracted DNA Calcium sensing receptor (CaSR gene mutation); Medullary thyroid cancer (RET gene mutation); Multiple endocrine neoplasia type 2 (MEN2); Nucleic acid analysis for specific variants; Sporadic and inherited neuroendocrine syndromes - Phaeochromocytomas and paragangliomas - SDHD,B,C,A TMEM127, fumarate hydratase, MAX gene mutations; Thyroid hormone receptor (THRB gene mutation)
Molecular genetics - Investigation of constitutional genetic variants - Diagnostic testing - Targeted genes Extracted DNA Calcium sensing receptor (CaSR gene mutation); Medullary thyroid cancer (RET gene mutation); Multiple endocrine neoplasia type 2 (MEN2); Nucleic acid analysis for specific variants; Sporadic and inherited neuroendocrine syndromes - Phaeochromocytomas and paragangliomas - SDHD,B,C,A TMEM127, fumarate hydratase, MAX gene mutations; Thyroid hormone receptor (THRB gene mutation); Von Hippel Lindau disease
Molecular genetics - Investigation of constitutional genetic variants - Diagnostic testing - Targeted panels for inherited (germline) DNA/RNA changes Extracted DNA Medullary thyroid cancer (RET gene mutation); Multiple endocrine neoplasia type 2 (MEN2); Nucleic acid analysis for unknown variants; Von Hippel Lindau disease
Molecular genetics - Predictive genetic testing - Targeted genes Purified DNA Calcium sensing receptor (CaSR gene mutation); Medullary thyroid cancer (RET gene mutation); Multiple endocrine neoplasia type 2 (MEN2); Nucleic acid analysis for known variants; Sporadic and inherited neuroendocrine syndromes - Phaeochromocytomas and paragangliomas - SDHD,B,C,A TMEM127, fumarate hydratase, MAX gene mutations; Thyroid hormone receptor (THRB gene mutation); Von Hippel Lindau disease
Molecular genetics - Predictive genetic testing - Targeted panels for inherited (germline) DNA/RNA changes Purified DNA Calcium sensing receptor (CaSR gene mutation); Medullary thyroid cancer (RET gene mutation); Multiple endocrine neoplasia type 2 (MEN2); Nucleic acid analysis for known variants; Sporadic and inherited neuroendocrine syndromes - Phaeochromocytomas and paragangliomas - SDHD,B,C,A TMEM127, fumarate hydratase, MAX gene mutations; Thyroid hormone receptor (THRB gene mutation); Von Hippel Lindau disease
Molecular genetics - Screening for an unknown mutation - Targeted genes Extracted DNA Calcium sensing receptor (CaSR gene mutation); Medullary thyroid cancer (RET gene mutation); Multiple endocrine neoplasia type 2 (MEN2); Nucleic acid analysis for unknown variants; Sporadic and inherited neuroendocrine syndromes - Phaeochromocytomas and paragangliomas - SDHD,B,C,A TMEM127, fumarate hydratase, MAX gene mutations; Thyroid hormone receptor (THRB gene mutation); Von Hippel Lindau disease
Molecular genetics - Screening for an unknown mutation - Targeted panels for inherited (germline) DNA/RNA changes Blood Calcium sensing receptor (CaSR gene mutation); Medullary thyroid cancer (RET gene mutation); Multiple endocrine neoplasia type 2 (MEN2); Nucleic acid analysis for unknown variants; Sporadic and inherited neuroendocrine syndromes - Phaeochromocytomas and paragangliomas - SDHD,B,C,A TMEM127, fumarate hydratase, MAX gene mutations; Von Hippel Lindau disease

The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.

Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.